Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche has received CE mark approval for its Elecsys pTau217 blood test, designed to aid in Alzheimer’s disease diagnosis by detecting amyloid pathology in patients with cognitive decline.
Roche has received CE mark approval for its Elecsys pTau217 blood test, designed to aid in Alzheimer’s disease diagnosis by detecting amyloid pathology in patients with cognitive decline.
The Elecsys NfL test measures a protein associated with nerve cell injury to monitor disease activity in patients with relapsing remitting multiple sclerosis.
Rapid immunoassays have emerged as a valuable tool for providing quick information that can be crucial in life-threatening situations.
Beckman Coulter Diagnostics' DxC 500i Clinical Analyzer has received FDA 510(k) clearance, improving networking capabilities.
Amsbio has launched ready-to-use DUB enzyme assay kits in a 96-well format to streamline deubiquitinase activity measurement.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...